• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    TiumBio Doses First Patient In Phase 2 Trial Of TU2218

    PR NEWSWIRE

    TiumBio Presents Promising Data For Hemophilia Treatment TU7710 At ISTH 2024

    PR NEWSWIRE

    TiumBio`s TU2218 Plus Pembro Phase 1b Interim Results At ASCO 2024

    PR NEWSWIRE

    TiumBio Positive Topline Phase 2a Data For Merigolix In Endometriosis

    PR NEWSWIRE

    TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710

    PR NEWSWIRE

    TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data

    PR NEWSWIRE

    TiumBio and Hansoh Announce Trial Approval of `HS-10518/TU2670`

    PR NEWSWIRE

    TiumBio inks licensing deal with China`s Hansoh for endometriosis drug

    KEDGLOBAL

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.